PDCD1 and neoplasm: Consistent with these findings, previous preclinical studies of [18F]F-AraG in a range of tumor models in mice have shown correlations of [18F]F-AraG tracer uptake with the frequency of CD8+ PD-1+ T cells in the tumors (10).